Veterinary medicines European public assessment report (EPAR): Stemyca, equine umbilical cord mesenchymal stem cells, Status: Opinion
Veterinary medicines European public assessment report (EPAR): Bovilis Lumpyvax, Lumpy skin disease vaccine (live), Status: Opinion
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 October 2026
EMA recommends authorisation of veterinary vaccine for lumpy skin disease in cattle
Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 7, Status: Authorised
Decision of the Management Board amending budget No. 01, amending appropriations in budget 2026 and transfer of appropriations
Applications for new human medicines under evaluation: October 2026
Human medicines European public assessment report (EPAR): Svariya (previously Rivaroxaban Koanaa), rivaroxaban, Date of authorisation: 21/11/2025, Revision: 3, Status: Authorised
Opinion/decision on a Paediatric investigation plan (PIP): Stelara, ustekinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: EMA/PE/0000245485
EMA/PE/0000247846